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Abstract: Normal-weight obesity (NWO) has been shown to be associated with cardiometabolic
dysfunction. However, little is known regarding this potential relationship in early adulthood.
The aim of this study was to investigate the associations between NWO and cardiometabolic risk
factors in a large population of Colombian young adults. A cross-sectional study was conducted on
1354 subjects (61% women), aged from 18 to 30. Anthropometric data, including body mass index
(BMI) and waist circumference (WC), were estimated, and the percentage of fat mass was measured
through bioelectrical impedance analysis (BIA). Muscular fitness was determined by using a handgrip
strength test and normalized grip strength (NGS = handgrip (kg)/body mass (kg)). A cardiometabolic
risk Z-score was derived by assessing WC, triglycerides, high-density lipoprotein cholesterol (HDL-C)
cholesterol, fasting glucose, and systolic blood pressure. NWO was defined by the combination of
excess %BF (over 25.5% for men and 38.9% for women) and a BMI < 25 kg/m2. The overall prevalence
of NWO was 29.1%. Subjects with NWO have an increased risk of cardiometabolic risk compared to
the normal-weight lean group (OR = 3.10). Moreover, NWO was associated with an increased risk of
presenting low HDL-C (OR = 2.34), high abdominal obesity (OR = 7.27), and low NGS (OR = 3.30),
p < 0.001. There is a high prevalence of NWO in American Latin young adults and this condition is
associated with an increased cardiovascular risk, high blood pressure, low HDL-C, high abdominal
obesity, and low muscular strength early in life. Screening for adiposity in subjects with a normal
BMI could help to identify young adults at a high risk of cardiometabolic abnormalities.
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1. Introduction
Excessive body fat increases the risk of other non-communicable diseases (NCD), such as
cardiovascular disease (CVD), chronic respiratory disease, metabolic disorders, and certain types of
malignant neoplasms [1,2]. Disturbances in adipose tissue function may induce alterations in adipose
tissue metabolism (i.e., lipid metabolism/lipolysis) and the storage capacity of dietary lipid in adipose
tissue. As a consequence, the body is not effectively able to adapt to its metabolic or energy demands,
also described as metabolic inflexibility [2]. Although different etiologies precede the development of
NCD, body fat accumulation is a major contributing risk factor, and is therefore a relevant target of
scientific research [3].
The World Health Organization (WHO) defines obesity as excessive body fat accumulation, which is
associated with several risks to health [1]. The body mass index (BMI), is used as a surrogate marker
for body fat and for classifying obesity, is positively associated with risk factors for cardiovascular and
metabolic diseases when BMI is above 18.5 kg/m2 [4]. However, BMI is not a very accurate measurement
for estimate adiposity in a particular individual since BMI does not take body composition (i.e., fat-free
mass vs. adipose tissue) into account. Thus, an individual with healthy BMI (18.5–24.9 kg/m2) may
have either an appropriate body fat percentage or an excessive body fat accumulation that might be
masked by the normal BMI [5].
In this context, excessive body fat, despite healthy body weight, has been described as normal-
weight obesity syndrome (NWO) [6]. NWO is a condition in which individuals who have normal body
weight and BMI but high body fat percentage, are at a greater risk of developing NCD [6–8]. In the
US population, estimates show that about 30 million Americans are affected by NWO [8]. Previous
studies have reported associations between NWO and metabolic disorders [9]. Similarly, individuals
aged >20 years with NWO were four-fold more likely to develop metabolic syndrome (MetSyn) than
those with normal BMI and healthy body fat percentage (16.6% vs. 4.8%) [8]. In females of Caucasian
origin aged 35–75 years from Switzerland, women with NWO had a higher cardiometabolic risk and
higher prevalences of high waist circumference (WC), high triglycerides, low high-density lipoprotein
cholesterol (HDL-C), and hyperglycaemia but a similar prevalence of hypertension compared to lean
women [10]. In addition, other studies have reported associations between NWO with the development
of dyslipidemia [11], insulin resistance [12], and changes in blood pressure [13] as well as pro-oxidative
effects and the exacerbation of low-grade chronic proinflammatory status in middle-aged adults [14].
Interestingly, a 7-year longitudinal study concluded that children and adolescents with NWO have an
increased risk for cardiometabolic morbidity in adulthood [15].
Thus far, only one study about NWO in Latin America has been published [16]. It included 1222
young adults aged 23 to 25 years with normal BMI, 55.3% of whom were women. The prevalence of
NWO (defined by the combination of excess body fat—the sum of triceps and subscapular skinfolds
>P90 of the study sample—and normal BMI) among the total sample was 9.1% (9.2% for men and 9.0%
for women). In this study, these authors also observed an association between NWO, low levels of
HDL-C (OR = 1.65), high triglycerides (OR = 1.93), and high WC (OR = 8.46).
Considering that body composition is not routinely assessed in outpatient care, it is important to
characterize NWO syndrome and to identify the health risks associated with this condition. To our
knowledge, there are few studies reporting an association between NWO and metabolic disorders
exclusively in young adults or coming from Latin American countries [16]. Therefore, the aim of the
present study was to evaluate the association between NWO and cardiometabolic risk factors in young
adults from Colombia.
2. Materials and Methods
2.1. Design and Study Population
This study was a secondary analysis of data from the FUPRECOL study, which is a
non-representative survey conducted between 2014 and 2017 on 1842 collegiate students (716 men
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and 1126 women) from Colombia. The design of the study and data collection has previously
been described in detail [17]. For this analysis, we used data from 1354 participants included as a
subsample with NWO-components. The participants answered a questionnaire (paper-and-pencil
format) containing information on socioeconomic, demographic, and behavioural variables (alcohol
intake, physical activity (PA) “proxy”, tobacco), and underwent physical examination when they were
18–30 years of age. Participants who had a clinical diagnosis of a major systemic disease, including
conditions such as cancer, systemic lupus erythematosus, diabetes mellitus, chronic inflammatory
conditions, such as rheumatoid arthritis, hypothyroidism or hyperthyroidism, multiple sclerosis, and
infectious conditions, were excluded from the analyses. Signed informed consent was obtained from
all FUPRECOL study participants. The protocol was in accordance with the Declaration of Helsinki
(World Medical Association for Human Subjects) and its later amendments. All procedures have been
approved by the ethics committee of the UMB (Code N◦ 01-1802-2013).
2.2. Anthropometric Measurements
All physical examinations were carried out by Level 2 experts certified by the International Society
for the Advancement of Kinanthropometry (ISAK) in accordance with ISAK guidelines [18]. Weight
was measured to the nearest 100 g using a scale (Model Tanita® BC-420®, Tokyo, Japan). Height
was measured to the nearest 0.1 cm using a stadiometer (Seca® 274, Hamburg, Germany). BMI was
calculated as body mass (kg)/height (m2). WC (abdominal obesity) was measured at the waist (at the
midpoint between the last rib and the iliac crest) after gentle expiration with a non-elastic flexible
tape measure (Lufkin W606PM®, Parsippany, NJ, USA), as recommended by the ISAK guidelines [18].
Waist-to-height ratio (WtHR) was calculated as the ratio of WC to height, with obesity defined as >0.49
for men and >0.50 for women according to previous reports [4]. NWO was defined as a BMI < 25 kg/m2
and a % body fat (%BF) over the gender-specific in collegiate students (25.5% for men and 38.9% for
women) [19].
The percentage of body fat (%), the visceral fat score/levels, and fat free mass (kg), were determined
by bioelectrical impedance analysis (BIA) (Tanita BC 420 MA/SC-331S®, Tokyo, Japan). The BIA Monitor
(Model BC 420 MA/SC-331S®) provides a visceral fat rating from 1–59, as previously described [20].
The fat mass index (FMI) was calculated by dividing each subject’s fat mass (kg) by the square of his/her
height (m), as previously described [21]. Then, four variables (the ratio of fat mass (kg) to fat free mass
(kg), the ratio of fat mass (kg) to handgrip strength (kg), and the ratio of handgrip strength (kg) to fat
free mass (kg)), normalized as handgrip strength to visceral fat level, were calculated [17,19,21].
2.3. Clinical Measurements
Blood samples were drawn in the morning after 10–12 h of fasting by a trained technician,
between 07:00 and 09:00 a.m. Capillary blood samples (40 µL) were collected to determine biochemical
parameters, including of fasting glucose, HDL-C, triglycerides (TG), and total cholesterol (TC),
using Cardiocheck® equipment (Mexglobal SA, Parsippany, NJ, USA). LDL-C was measured using
Friedewald’s Formula LDL-C = Total Cholesterol − HDL-C − TG/5 if triglyceride values were ≤ 400
mg/dL [22].
For the blood pressure (BP) measurements, we used an Omron® digital sphygmomanometer
model HEM 705 CP (Omron® Healthcare Europe B.V., Hoofddorp, Netherlands), with the participants
seated, following the recommendations of the European Heart Society [23], after 5 min rest. The mean
arterial blood pressure (MAP) was calculated as MAP = diastolic BP + (0.333 × (systolic BP × 2
diastolic BP)).
A cardiometabolic risk Z-score (CMR) was created from the sum of systolic (BP), TG, WC, HDL-C,
and fasting glucose Z-score [24]. This cluster was constructed as the sum of the Z-scores of each
variable, which was calculated as follows: (value − mean)/standard deviation (SD), separately for men
and women, and for each 1-year age group. Individuals with a cardiometabolic risk Z-score + 1 SD
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above the mean were identified as having increased cardiometabolic risk, with a lower cardiometabolic
risk Z-score being indicative of a healthier risk profile.
Grip strength was tested by a digital dynamometer (T.K.K. 5401, Grip-D Smedley, Takei, Japan),
with adjustment for the hand size of each participants. The best score for each hand was recorded in
kilograms (kg), accurate to one decimal place, and the score (kg) was calculated as the average of the
scores for the left and right hands [20]. The grip strength was normalized as handgrip strength (NGS)
per body mass, i.e., (handgrip strength in kg)/(body mass in kg).
To assess the degree of adherence to the Mediterranean diet (MedDiet), the validated 14-item
Mediterranean Diet Adherence questionnaire was administered [25]. This tool was developed in the
PREDIMED study [26]. This questionnaire comprises 12 items about food consumption frequency
and two on the consumption habits of foods considered characteristic of the Med Diet pattern. Each
question is scored either 0 or 1 and the total score ranges from 0 to 14; the higher the score, the greater
the adherence to the Med Diet.
2.4. Statistical Analysis
The sample characteristics were presented as the mean and standard deviation (SD) for continuous
variables, and frequencies and percentages were calculated for categorical variables. Both statistical
(Kolmogorov–Smirnov test) and graphical methods (normal probability plots) were used to examine the
fit to a normal distribution for each continuous variable. Due to their skewed distribution, all dependent
variables were log-transformed before to be included in the models. To aid interpretation, the data
were back-transformed from the log scale for presentation in the results (Table 1).
Analysis of covariance (ANCOVA) was used to compare means to explore group differences
(i.e., NWL vs. NWO), adjusted for age and sex. Finally, the odds ratios (ORs) and 95% confidence
interval (CI) for cardiometabolic risk factors were calculated in each group using a multiple logistic
regression analysis after adjusting for age and sex (Model 1). The analysis was further adjusted for
physical activity, alcohol intake, tobacco status, and healthy diet (Model 2). All p-values presented
are two-tailed, and p-values of <0.05 were considered to indicate statistical significance. Statistical
analyses were performed with SPSS ver. 24.0 for Windows (SPSS, Inc., Chicago, IL, USA).
3. Results
The number of normal-weight subjects included in the study was 1354 (61% females).
Most anthropometric, physical, and cardiometabolic characteristics differed significantly between
women and men (all p < 0.05), except for age (p = 0.215), triglycerides (p = 0.172), and cardiometabolic
risk Z-score (p = 0.834). Low HDL-cholesterol was significantly higher in women (67.5%) than in
men (50.1%), whereas high blood pressure was higher in men (35.0%) compared with women (12.4%).
High LDL-cholesterol was also higher in men (27.0%) than in women (18.2%). High WtHR, WC,
fat mass index, the ratio of fat mass (kg) to fat free mass (kg), the ratio of fat mass (kg) to handgrip
strength (kg), the ratio of handgrip strength (kg) to fat free mass (kg), the NGS to visceral fat level
ratio, glycemia, triglycerides, cardiometabolic risk Z-score (+1 SD above the mean), alcohol intake, or
smoking did not differ by sex.
For the purpose of the present study, the analyses were restricted to the NWL and NWO groups.
In the sample, 29.1% had NWO (46.0% women). Regarding anthropometrics parameters, the NWO
group had significantly higher values for body weight, height, WC, fat free mass, visceral fat level,
fat mass index, the ratio of fat mass (kg) to fat free mass (kg), the ratio of fat mass (kg) to handgrip
strength (kg), the ratio of handgrip strength (kg) to fat free mass (kg), and the NGS to visceral fat level
ratio (all p < 0.001), than the NWL group. In addition, systolic BP, diastolic BP, MAP, total cholesterol,
LDL-C, TG, fasting plasma glucose, and cardiometabolic risk Z-score were significantly greater in
NWO compared to those in the NWL group, and smaller in HDL-C (all p < 0.05). Finally, the NWO
group was weaker compared to the NWL group (7.2% versus 15.8%, p < 0.05).
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Table 1. Characteristics of the study sample of normal-weight lean (NWL) and normal-weight obesity
(NWO) participants.
Characteristics Women(n = 826)
Men
(n = 528)
NWL
(n = 961)
NWO
(n = 393)
Age (years) 20.4 ± 2.2 20.2 ± 2.1 20.1 ± 2.1 20.8 ± 2.2 **
Anthropometric parameters
Body weight (kg) 54.4 ± 6.2 64.1 ± 7.9 ** 57.7 ± 9.4 59.1 ± 4.9 **
Height (cm) 159.2 ± 5.8 172.2 ± 6.5 ** 165.6 ± 9.4 160.9 ± 5.6 **
Body mass index (kg/m2) 21.4 ± 2.1 21.6 ± 2.1 ** 20.9 ± 1.5 22.8 ± 1.5 **
Waist circumference (cm) 68.3 ± 5.4 74.6 ± 5.9 ** 70.3 ± 6.9 71.9 ± 4.6 **
WtHR 0.43 ± 0.04 0.43 ± 0.03 * 0.42 ± 0.03 0.44 ± 0.03 **
Fat free mass (kg) a 41.0 ± 3.0 55.5 ± 5.9 ** 47.8 ± 9.1 42.3 ± 2.3 **
Visceral fat level 1.3 ± 0.9 1.5 ± 1.1 ** 1.3 ± 0.9 1.7 ± 1.0 **
Fat mass index (kg/m2) 6.50 ± 2.75 3.81 ± 2.24 ** 3.39 ± 1.23 6.56 ± 0.85 **
Ratio of fat mass (kg) to fat free mass (kg) 0.38 ± 0.14 0.18 ± 0.10 ** 0.19 ± 0.08 0.39 ± 0.04 **
Ratio of fat mass (kg) to handgrip strength (kg) 0.69 ± 0.31 0.29 ± 0.18 ** 0.32 ± 0.16 0.71 ± 0.16 **
Ratio of handgrip strength (kg) to fat free mass (kg) 0.57 ± 0.12 0.68 ± 0.12 ** 0.63 ± 0.14 0.57 ± 0.10 **
Ratio of NGS to visceral fat level 0.30 ± 0.17 0.38 ± 0.25 ** 0.47 ± 0.16 0.29 ± 0.13 **
Muscular fitness
Handgrip strength (kg) 23.8 ± 4.6 38.8 ± 7.1 ** 31.6 ± 9.8 24.7 ± 4.9 **
NGS (kg/kg) 0.44 ± 0.08 0.61 ± 0.11 ** 0.54 ± 0.12 0.42 ± 0.08 **
Weak NGS, ≤ 0.47 kg in men and ≤ 0.33 kg in women, % 10.3 8.7 7.2 15.8 *
Cardiometabolic parameters
Systolic blood pressure (mmHg) 109.9 ± 11.0 118.2 ± 12.3 ** 112.1 ± 12.7 115.5 ± 10.8 **
Diastolic blood pressure (mmHg) 70.9 ± 8.2 72.5 ± 10.0 * 71.1 ± 9.3 72.5 ± 8.2 *
Mean arterial pressure (mmHg) 90.4 ± 8.7 95.5 ± 10.5 ** 91.7 ± 10.2 94.0 ± 8.4 **
Total cholesterol (mg/dL) 145.5 ± 34.1 131.0 ± 28.9 ** 137.6 ± 32.5 145.3 ± 33.2
LDL-C (mg/dL) 87.0 ± 26.2 80.2 ± 25.8 ** 82.9 ± 25.1 87.9 ± 28.3
HDL-C (mg/dL) 45.5 ± 12.7 40.8 ± 10.4 ** 44.5 ± 12.0 41.8 ± 12.2 *
Triglycerides (mg/dL) 82.7 ± 40.9 85.8 ± 39.0 83.4 ± 39.8 85.1 ± 41.0
Fasting plasma glucose (mg/dL) 85.3 ± 12.0 83.5 ± 11.8 * 84.4 ± 12.0 85.2 ± 11.6
Cardiometabolic risk Z-score −0.85 ± 2.25 −0.87 ± 2.30 −1.17 ± 2.24 −0.09 ± 2.16 **
Increased cardiometabolic risk, %
HTA, ≥130 mm Hg SBP and/ or DBP 85 mm Hg 12.4 35.0 ** 16.4 23.2 *
Hyperglycemia, ≥5.6 mmol/L [100 mg/dL] 8.2 7.1 7.3 9.0
High triglycerides, ≥1.7 mmol/L [151 mg/dL] 5.0 7.3 5.9 6.0
High LDL-C, ≥2.6 mmol/L [100 mg/dL] 27.0 18.2 * 21.4 29.1
Low HDL-C < 1 mmol/L [38.7 mg/dL] in men and 1.3
mmol/L [50.3 mg/dL] in women 67.5 50.1 ** 56.3 71.6 *
Obesity, WC ≥ 90 cm in men, and ≥ 80 cm in women 1.3 1.0 0.6 2.6 *
Obesity, WtHR > 0.49 in men and > 0.50 in women 1.8 2.9 1.7 3.6 *
Cardiometabolic risk Z-score, + 1 SD above the mean 19.5 18.3 15.4 27.9 *
Self-report lifestyles, %
Adherence Mediterranean Diet 14.8 10.1 * 12.8 12.3
Alcohol (≥1 times/week) 5.4 7.6 6.1 9.0
Tobacco (≥10 cigarettes/week) 26.6 29.2 23.5 29.9
Physical activity “proxy” ≥ 150 min/week 29.7 37.2 * 35.3 24.9 *
The results are shown as mean and standard deviation (SD) for continuous variables, and percentages (%) for
categorical variables. HDL-C, High-density lipoprotein cholesterol; LDL-C, Low-density lipoprotein cholesterol;
NGS, normalized as handgrip strength. WC, waist circumference; WtHR, Waist-to-height ratio; HTA, hypertension;
SBP, systolic blood pressure; DBP, diastolic blood pressure. Physical activity was assessed as an accumulated time of
150 min/week or more, undertaking moderate- to vigorous-intensity physical activity, which was considered to meet
physical activity recommendations for adults. Alcohol consumption and smoking status were defined as subjects
who had consumed any alcoholic beverage ≥1 times/week, and those who had smoked ≥10 cigarettes/week, for at
least 6 months, as previously described by Ramírez-Vélez et al. (19). Participants who exercised five times a week
for >30 min were categorised as ‘physically active’. Analysis adjusted for age and sex. a Fat free mass is comprised
of muscle, bone, tissue, water, and all other fat free mass in the body; * p < 0.05; ** p < 0.001.
High blood pressure, low HDL-cholesterol, abdominal obesity, obesity by high WtHR,
high cardiometabolic risk Z-score, and weak NGS were significantly higher in NWO compared
to NLW in women (all p < 0.05), whereas obesity and weak NGS only in men (p < 0.05), Figure 1.
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Figure 1. Differences in cardiometabolic risk parameters muscular fitness between NLW and NWO.
HTA, hypertension; LDL-C, Low-density lipoprotein cholesterol; HDL-C, High-density lipoprotein
cholesterol; CMR, cardiometabolic risk; NGS, normalized as handgrip strength. * p < 0.01.
The adjusted ORs for having cardiometabolic risk factors in the NWO group were investigated
using a multiple logistic regression analysis and compared to those of the NWL group (Figure 2).
Age and sex in Model 1 (M1), in addition to smoking status, alcohol intake, physical activity “proxy”,
and adherence to the Mediterranean diet in Model 2 (M2), were adjusted in the multiple logistic
regression analysis. After adjustment for age and sex (Model 1), high blood pressure (OR = 1.60, 95%CI
1.07–2.40), low HDL-C (OR = 1.56, 95%CI 1.16–2.10), abdominal obesity (OR = 6.16, 95%CI 1.47–25.71),
obesity for high WtHR (OR = 4.40, 95%CI 1.49–12.94), high cardiometabolic risk Z-score (OR = 2.97,
95%CI 2.07–4.27), and weak NGS (OR = 2.98, 95%CI 1.87–4.76) were t e potential factors with the
highest values in the risk of occurrence of the NWO group (p < 0.05). In addition, the results from
multiple logistic regression analyses in Model 2 were also consistent except for high blood pressure
(OR = 1.42, 95%CI 0.89–2.27), and obesity for high WtHR (OR = 2.61, 95%CI 0.69–9.87), Model 2.
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Figure 2. Multiple logistic regression analysis for having cardiometabolic risk factors in the NWO
group. The adjusted odds ratios (ORs) for having cardiometabolic risk factors in the NWO group were
investigated using a multiple logistic regression analysis and compared to those of the NWL group
(Ref). HDL-C, High-density lipoprotein cholesterol; LDL-C, Low-density lipoprotein cholesterol; NGS,
normalized as handgrip strength; Model 1 (M1) adjusted for age and sex; Model 2 (M2) adjusted for the
same covariates as Model 1 and physical activity “proxy”, alcohol intake, smoking, and adherence
Mediterranean diet.
4. Discussion
The presence of cardiometabolic risk factors in early ages has bee ssociated with the earlier
onset of chronic conditions, including iabetes, heart disease, and risk of early mortality [27]. Thus,
to identify whether the condition of NWO is linked to a cardiometabolic risk profile in young adults is
especially relevant. This study reported that NWO was associated with an inc eased car iov scular
risk, high blood pressure, low HDL-C, high abdominal obesity, and low muscular strength in a large
cohort of young adults from Colombia, supporting that there is a high prevalence of clustering of
cardiometabolic abnormalities among subjects with NWO. Due to the deleterious effect of NWO on
cardiometabolic profile, adiposity should be routinely assessed in clinical practice in order to identify
young adults with an NWO condition. Failure to recognized NWO in early adulthood may contribute
to the lack of prescription to adopt healthy lifestyle changes that might prevent future cardiometabolic
disturbances later in life.
In this study, differences in the obesity groups according to age (effect size = 0.325), height (effect
size = 0.607), and BMI (effect size = 0.095) were identified. Although both parameters are important
factors associated with fatness among young people, it should be noted that these differences have
a relatively small to moderate clinical significance that may be due to the non-probability sampling
design study. Despite this, all comparisons were adjusted for age and sex (M1).
In our study, the overall prevalence of NWO, defined by the combination of excess %BF (over
25.5% for men and 38.9% for women) and a BMI < 25 kg/m2, was 29.1%. Note that that 2.0% of the
men and 46% of the women students were classified as NWO. These findings evidenced the important
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prevalence of NWO during early adulthood in a Latin American population. Among the same line,
Kim et al. [28] reported a prevalence of 32% of NWO in Korean adults aged 20 years or older and
Romero-Corral et al. [8]. found an overall prevalence of 33.4% in Americans. These results differ
from the results from Madeira et al. [16], who reported that the prevalence of NWO among Brazilian
young adults aged 23–25 years was 9.1%. However, it should be noted that, in this study, body fat was
estimated by measuring skinfold thickness and the cutoff point for NWO was the 90th percentile of the
sum of the subscapular and triceps skinfolds. Similarly, using the highest tertile of body fat percentage
as the cutoff value, in a study conducted in adults aged 35–75 years from Switzerland, the prevalence
of NWO was 5.4% in women and less than 3% in men [14]. Therefore, the discrepancies in the NWO
prevalence data might be due to the lack of consensus regarding diagnostic criteria, characteristics of
the participants (age, lifestyle, dietary habits), and ethnic differences in study cohorts [9].
In agreement with previous findings, the current study supports the notion that young adults
with a normal BMI but excessive fatness perform worse on the six measures of fatness (WC, WtHR,
fat free mass, fat mass index, visceral fat level, and fat mass to fat free mass ratio), muscular fitness
parameters, and combined fitness vs. fatness index (ratio of fat mass to handgrip strength, ratio of
handgrip strength to fat free mass, and ratio of NGS to visceral fat level) [29]. To illustrate the degree
to which both concepts overlap, we reported the prevalence of each obesity group according to the
NGS to visceral fat level ratio quartiles (first quartile (Q1 lowest group, “unhealthy”), second quartile
(Q2), third quartile, (Q3) and fourth quartile (Q4 highest group, “healthy”), Figure 3. The category
containing the NWL group was 1.8% in Q1, 16.3% in Q2, 35.6% in Q3, and 42.6% in Q4. In addition,
the proportions of subjects with NWO were 8.0% in Q1, 49.8% in Q2, 31.6% in Q3, and 10.5% in Q4.
These findings indicate that those subjects positioned in Q4 and the NWL group present better body
composition than the NWO group (42.6% vs. 10.5%), within normal BMI values, p < 0.001.
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Figure 3. Mosaic plot depicting the frequency of participants (%) in each obesity group (NWL, NWO)
and quartiles (Q1 to Q4) to NGS and the visceral fat level ratio. Normal-weight lean (NWL) and
normal-weight obesity (NWO). Q1 (lower or “unhealthy” group), p < 0.001. The NGS to visceral fat level
ratio was divided into quartiles with the following (min–max) values: Q1: 0.01–0.13, Q2: ≥0.13–0.33,
Q3: ≥0.33–0.49 and Q4: >0.49–0.99.
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An increase in body composition markers is considered a risk factor for cardiovascular disease in
young adults [30,31] and, in this study, after adjusting for a potential confounding factors, the NWO
group had higher ORs for “proxy” indicators of adiposity (WtHR) than the lean group. Our results are
in line with the previous study that reported an association between increased abdominal adiposity
and WHtR and cardiovascular disease and cardiovascular risk factors even among subjects with a
normal BMI [32–34]. In our present study, the participants in Q1 to Q2 showed the lowest prevalence
of NGS to visceral fat level ratio (18.1%) in the NWL group, whereas the NWO group showed a higher
prevalence of NGS to visceral fat level ratio (57.8%), p < 0.001. In agreement with these findings,
previous studies conducted on young people have reported an inverse association between muscle
mass, body composition markers and/or metabolic profile, and cardiovascular risk factors [35–37].
Therefore, the body composition is an essential tool for estimating cardiometabolic risk and identifying
young adults within normal BMI values.
Considering the interaction of reduced skeletal muscle mass/muscular strength with elevated
fatness markers, we used the three surrogate index (ratio of fat mass to fat free mass, ratio of fat mass
to handgrip strength, and ratio of handgrip strength to fat free mass) to investigate its relationship with
NWO syndrome. For example, we found that young adults with NWO showed significantly lower
handgrip strength (in terms of relative and absolute values) to fat free mass compared to subjects with
NWL, with healthy BMI values. In line with our results, reduced skeletal muscle mass and visceral fat
area were reported to increase the risk of metabolic impairment more than any other single factor alone
in Korean adults with metabolic syndrome and type 2 diabetes [38] or college students in Colombia [35].
Similarly, in a longitudinal study (7 years), Wiklund et al. [15] found that NWO girls (from age 11
to 18) had a greater amount of body fat and a stable lean mass/fat mass ratio index from childhood
to adulthood compared to their healthy weight and healthy BMI peers. Taken together, the results
suggest that it would be of interest that clinical physicians identify subjects with a high risk of NWO.
NWO is a state in which an excessive amount of fatness markers and decreased lean mass is
accompanied by average/normal BMI values. In this line, we demonstrated that the excess of body fat in
subjects with NWO has an increased risk of cardiometabolic risk Z-score compared to NWL (OR = 3.10).
Moreover, NWO was associated with an increased risk of presenting low HDL-C (OR = 2.34), high
abdominal obesity (OR = 7.27), and low muscular strength (OR = 3.30). These findings are in agreement
with a previous study conducted in young adults from a middle-income country that found associations
between components of the metabolic syndrome, including high waist circumference and low HDL-C
early in life [16]. Marques-Vidal also concluded that swiss women aged 35–75 with NWO present
higher cardiovascular risk factors than lean women [14] and Moy et al. [39] indicated that women with
NWO had cardiometabolic abnormalities, including abdominal obesity, dyslipidemia, and increased
blood pressure. Another study carried out using data from the Third National Health and Nutrition
Examination Survey (NHANES III) in adults > 20 years demonstrated that subjects with NWO also have
a higher prevalence of dyslipidemia, hypertension, and cardiovascular disease [8], and Shea et al. [11]
Interestingly, a large study that estimated %BF with air displacement plethysmography showed that
non-obese individuals according to BMI but obese based on body fat have higher values of WC, blood
pressure, triglycerides, glucose, insulin, HOMA, and lower values of HDL-C [40]. Indeed, for the first
time, we found that NWO is also associated with low muscular fitness in early adulthood. In this line,
a recent study reported that NWO is associated with poorer physical fitness and the relationship is
partially mediated by lower skeletal muscle mass in Chinese university students [29]. It should be
highlighted that, similar to the study of Madeira et al. [16], no association was observed in our study
between NWO and high blood pressure in the fully adjusted model. Note that this study and our
research were conducted only in cohorts of young adults, whereas the above-mentioned studies were
carried out in populations with wide age ranges. Thus, differences in risk estimates between NWO
and cardiometabolic disturbances might be explained by differences in the age and ethnicity of the
study populations and the lack of consensus regarding the NWO definition.
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Supporting our observations, previous studies have also shown that only measuring BMI might
not be sufficient criteria for identifying individuals at cardiometabolic risk since it might fail to identify
subjects who, despite having a normal BMI, present an excess of adiposity and are also at a high risk of
cardiometabolic imbalances and, consequently, cardiovascular diseases. This study provides important
insights into understanding obesity since it states that a normal BMI might not necessarily imply
cardiometabolic protection. The screening of NWO might be useful for clinicals in order to implement
effective strategies to prevent cardiometabolic diseases. In addition, taking into account that NWO is
associated with an increased risk of cardiometabolic risk, there is a need to establish an appropriate
criterion to define NWO. Our research might also encourage authors to reach a consensus regarding
the diagnostic criteria for NWO. Interestingly, since recent studies indicated that oral condition might
affected metabolic risk [41,42], it should of interest to examine the potential relationship between NWO
and oral health.
This study has potential limitations that should be addressed. First, the cross-sectional design
does not allow us to explain causality. Second, the prevalence of NWO was low (39.1% in the overall
population, 46.0% in women, and 2.0% in men), which might limit the generalizability of our results.
However, this prevalence is similar to that reported in other epidemiological studies [14]. Thus, future
prospective analysis is necessary to determine any relationship between the NWO condition and
cardiometabolic risk factors. Third, our study comprised a non-representative sample of young adults
from Colombia, making the generalizability of the results to populations with different characteristics
difficult. Last, the study population included only university students. However, this also might be
considered as a strength since it eliminates the potential confounding effect of age. Despite these
limitations, the main strength of our study is that, to our knowledge, this is the largest research on the
relationship between NWO and cardiometabolic risk in a population of Latin American young adults.
Furthermore, highly standardized procedures were developed within the FUPRECOL study to avoid
measurement bias. Additionally, statistical models were adjusted for several variables, including age,
sex, smoking, alcohol intake, physical activity “proxy”, or healthy diet.
5. Conclusions
In conclusion, there is a high prevalence of NWO in American Latin young adults, and this
condition is associated with an increased cardiovascular risk, high blood pressure, low HDL-C,
high abdominal obesity, and low muscular strength early in life. Our results suggest that screening
for adiposity in subjects with a normal BMI could help to identify young adults at a high risk of
cardiometabolic abnormalities.
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